Efficacy and Safety of Tildrakizumab in Older Patients: Pooled Analyses of Two Randomized Phase III Clinical Trials (reSURFACE 1 and reSURFACE 2) Through 244 Weeks
出版年份 2023 全文链接
标题
Efficacy and Safety of Tildrakizumab in Older Patients: Pooled Analyses of Two Randomized Phase III Clinical Trials (reSURFACE 1 and reSURFACE 2) Through 244 Weeks
作者
关键词
-
出版物
ACTA DERMATO-VENEREOLOGICA
Volume 103, Issue -, Pages adv17752
出版商
Medical Journals Sweden AB
发表日期
2023-10-25
DOI
10.2340/actadv.v103.17752
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Drug Survival, Safety, and Effectiveness of Biologics in Older Patients with Psoriasis: A Comparison with Younger Patients—A BioCAPTURE Registry Study
- (2022) E. L. M. ter Haar et al. DRUGS & AGING
- Safety Assessment of Conventional and Biological Systemic Therapy in Older Adults with Psoriasis, a Real-world Multicentre Cohort Study
- (2022) Elke L.M. Ter Haar et al. ACTA DERMATO-VENEREOLOGICA
- Real‐world effectiveness and safety of tildrakizumab in long‐term treatment of plaque psoriasis: Results from the non‐interventional, prospective, multicentre study TILOT
- (2022) Athanasios Tsianakas et al. JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY
- Five‐year efficacy and safety of tildrakizumab in patients with moderate to severe psoriasis who respond at week 28: pooled analyses of two randomised phase 3 clinical trials (reSURFACE 1 and reSURFACE 2)
- (2021) D. Thaçi et al. BRITISH JOURNAL OF DERMATOLOGY
- Anti‐interleukin‐23 for psoriasis in elderly patients: guselkumab, risankizumab and tildrakizumab in real‐world practice
- (2021) A. Ruggiero et al. CLINICAL AND EXPERIMENTAL DERMATOLOGY
- Effective and Safe Treatment of Psoriatic Disease with the Anti-IL-23p19 Biologic Tildrakizumab: Results of a Real-World Prospective Cohort Study in Nonselected Patients
- (2021) Katharina A. Drerup et al. DERMATOLOGY
- Comparison of Biologics and Oral Treatments for Plaque Psoriasis
- (2020) April W. Armstrong et al. JAMA Dermatology
- Evaluation of the Frequency of “Not Relevant” Responses on the Dermatology Life Quality Index by Sociodemographic Characteristics of Patients With Psoriasis
- (2020) John S. Barbieri et al. JAMA Dermatology
- The risk of respiratory tract infections and symptoms in psoriasis patients treated with IL-17-pathway inhibiting biologics: A meta-estimate of pivotal trials relevant to decision-making during the COVID-19 pandemic
- (2020) Marilyn T. Wan et al. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY
- Dermatology Life Quality Index (DLQI) score bands are applicable to DLQI‐Relevant (DLQI‐R) scoring
- (2020) F. Rencz et al. JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY
- Elderly patients with psoriasis: Long-term efficacy and safety of modern treatments
- (2020) Katerina Bakirtzi et al. JOURNAL OF DERMATOLOGICAL TREATMENT
- Quality of life, treatment goals, preferences and satisfaction in older adults with psoriasis: a patient survey comparing age groups
- (2020) M.E.C. Winden et al. BRITISH JOURNAL OF DERMATOLOGY
- Responsiveness of the EQ‐5D‐3L, DLQI, and DLQI‐R for Patients With Psoriasis in the United States
- (2019) J. Barbieri et al. BRITISH JOURNAL OF DERMATOLOGY
- Influence of “Not Relevant” Responses on the Dermatology Life Quality Index (DLQI) for Patients With Psoriasis in the United States
- (2019) John S. Barbieri et al. JAMA Dermatology
- Long‐term efficacy and safety of tildrakizumab for moderate‐to‐severe psoriasis: pooled analyses of two randomized phase III clinical trials (re SURFACE 1 and re SURFACE 2) through 148 weeks
- (2019) K. Reich et al. BRITISH JOURNAL OF DERMATOLOGY
- Representation of older adults in randomized controlled trials on systemic treatment in plaque psoriasis: A systematic review
- (2019) Mirjam J. Schaap et al. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY
- DLQI‐R scoring improves the discriminatory power of Dermatology Life Quality Index in psoriasis, pemphigus and morphea patients
- (2019) F. Rencz et al. BRITISH JOURNAL OF DERMATOLOGY
- Proposal of a new scoring formula for the DLQI in psoriasis
- (2018) F. Rencz et al. BRITISH JOURNAL OF DERMATOLOGY
- Psoriasis and the metabolic syndrome
- (2018) Paolo Gisondi et al. CLINICS IN DERMATOLOGY
- Elderly psoriatic patients under biological therapies: an Italian experience
- (2018) F Ricceri et al. JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY
- Inappropriate Use of Medication by Elderly, Polymedicated, or Multipathological Patients with Chronic Diseases
- (2018) Virtudes Pérez-Jover et al. International Journal of Environmental Research and Public Health
- Prevalence and incidence of psoriasis and psoriatic arthritis
- (2018) Philipp Sewerin et al. ANNALS OF THE RHEUMATIC DISEASES
- Does the Dermatology Life Quality Index (DLQI) underestimate the disease-specific burden of psoriasis patients?
- (2018) A. Langenbruch et al. JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY
- Tildrakizumab: A Review of Phase II and III Clinical Trials
- (2018) Sree S. Kolli et al. ANNALS OF PHARMACOTHERAPY
- A detailed analysis of ‘not relevant’ responses on the DLQI in psoriasis: potential biases in treatment decisions
- (2017) F. Rencz et al. JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY
- Tildrakizumab versus placebo or etanercept for chronic plaque psoriasis (reSURFACE 1 and reSURFACE 2): results from two randomised controlled, phase 3 trials
- (2017) Kristian Reich et al. LANCET
- Adverse drug reactions in special populations - the elderly
- (2015) E. A. Davies et al. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
- Psoriasis in the elderly: epidemiological and clinical aspects, and evaluation of patients with very late onset psoriasis
- (2014) C. Phan et al. JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY
- Clinical study of psoriasis occurring over the age of 60 years: is elderly-onset psoriasis a distinct subtype?
- (2011) Hyuck Hoon Kwon et al. INTERNATIONAL JOURNAL OF DERMATOLOGY
- Safety of treatment with biologics for psoriasis in daily practice: 5-year data
- (2011) P.P.M. van Lümig et al. JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY
- Epidemiology of comorbidities in psoriasis
- (2010) Luigi Naldi et al. Dermatologic Therapy
- Heart Disease and Stroke Statistics—2010 Update
- (2009) et al. CIRCULATION
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationPublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More